Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

EAB GROUP PLC: ACQUISITION OF OWN SHARES 02.03.2020

EAB GROUP PLC NOTIFICATION 02.03.2020 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 02.03.2020   Date 02.03.2020  Exchange transaction Buy  Share class EAB  Amount 200  Average price/share 2.8600 EURHighest price/share 2.8600 EURLowest price/share 2.8600 EURTotal price 572.00 EUR      The shares held by EAB Group Plc on 02.03.2020:   EAB 14,094     On behalf of EAB Group Plc  Skandinaviska Enskilda Banken

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 02.03.2020

Fiskars Corporation NOTIFICATION 02.03.2020 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 02.03.2020   Date 02.03.2020  Exchange transaction Buy  Share class FSKRS  Amount       1,000  Average price/share 10.9450 EURHighest price/share 11.1200 EURLowest price/share 10.8600 EURTotal price 10,945.00 EUR      The shares held by Fiskars Corporation on 02.03.2020:     FSKRS  428,677     On behalf of Fiskars

Estimation of Coronavirus's impact on Vitrolife's sales

Vitrolife estimates that sales in the Asia region will decrease by approximately 30 percent in the first quarter and that the vast majority of patients scheduled to undergo IVF treatments in the first quarter will complete these at a later date.In conjunction with the report on operations, Vitrolife informed that the Corona virus was considered to have a negative impact on sales to China during the first quarter as a result of reduced demand. Vitrolife can now assess the effect of the Corona virus on the company's sales in the first quarter and estimates that sales in the Asia region will

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Valby, Denmark, 2 March 2020 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck. 1. Details of the person discharging managerial responsibilities / person closely associateda) Name Deborah Dunsire2. Reason for the notificationa) Position/status President and CEOb) Initial Initial notification notification/Amen dment3. Details of  the issuer,  emission  allowance

European Lingerie Group AB publishes unaudited 12 Months and Fourth Quarter 2019 Report and provides an update on the Amended Bond Terms and Conditions

European Lingerie Group AB („ELG“ or the „Group“) publishes unaudited 12 Months and Fourth Quarter 2019 Report (1 January – 31 December 2019), including pro forma and condensed interim consolidated financial statements.· The Group reported in the report for nine months and third quarter 2019 that the Group’s Net Interest Bearing Debt to EBITDA ratio exceeded the maximum 4.25 allowed under the maintenance test of the Original Bond Terms and Conditions issued on 22 February 2018.  · On 13 December 2019, the Parent company of the Group announced that it is formally initiating a written

Össur hf: Transactions in relation to share buyback program

Announcement no. 18/2020 2 March 2020  Transactions in relation to share buyback program On 17 February 2020, Össur hf. initiated a share buy-back program, see Company announcement no. 13/2020. The purpose of the share buyback program was to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program would end no later than 31 May 2020. The Company could purchase up to 2,500,000 shares under the program, corresponding to 0.59% of the current share capital.

Issue and repurchase of series C shares for share saving program

Pursuant to the authorization granted by the annual general meeting on 14 November 2019, the board of directors of Ascelia Pharma AB (”Ascelia”) has resolved to issue and immediately thereafter repurchase  510,545 series C shares. The shares are issued and repurchased in accordance with the share saving program LTI 2019, which was adopted by the annual general meeting on 14 November 2019.Pursuant to the authorization granted by the annual general meeting on 14 November 2019, the board of directors of Ascelia has resolved on a directed issue of 510,545 series C shares to Svenska

SEB's annual reporting 2019 published

SEB's Annual Report, which includes the Sustainability Report, and the Report on Capital Adequacy and Risk Management, are now available at SEB's website, together with SEB's Green Bond Investor Report. 2019 was the first year of SEB’s three-year business plan. SEB’s focus and activities were concentrated to the strategic focus areas – advisory leadership, operational excellence and extended presence – where progress was in line with plan. The investments in strategic initiatives, which aim to accelerate growth and enhance profitability by leveraging new adjacent business opportunities,

Norwegian Energy Company ASA: Share buyback

Reference is made to the stock market announcement on 27 February 2020, where Norwegian Energy Company ASA ("Noreco" or the "Company") announced an initiation of a share buyback programme of up to 160,000 of its own shares. Noreco has on 2 March 2020 purchased 1,151 of its own shares at an average price of NOK 199.1133 per share. After this transaction the Company holds a total of 303,826 own shares. The transaction is completed in accordance with the authorization given by Noreco's annual general meeting on 28 June 2018, which is valid until 28 June 2020. The information is

#20-73 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Resolutions at extraordinary general meeting in Eniro

Eniro AB (publ) (“Eniro” or “the Company”) today held its Extraordinary General Meeting (“EGM”). The EGM resolved, in accordance with the Board of Director’s proposal on amendments of the Articles of Association and authorisation for the Board of Directors to issue shares etc. In light of the plan for a recapitalisation of the Company which has previously been communicated whereby holders of convertibles and bonds in Eniro is offered to exchange their convertibles and bonds for a new class of preference shares, preference shares of series A, the EGM held today resolved to approve

Addtech acquires DMC Digital Motor Control GmbH and Q-tronic B.V.

Addtech Power Solutions, a business area in the Addtech Group, has today signed an agreement to acquire 100% of the shares in DMC Digital Motor Control GmbH (“DMC”) and Q-tronic B.V. (“Q-tronic”). DMC designs and produces electrical motor controllers for battery driven applications including electrical vehicles. The company is based in Germany, with sales mainly throughout Europe. Q-tronic provide electrical component solutions and subsystems for electrical vehicles in mainly Benelux countries. Together DMC and Q-tronic have a turnover of approximately EUR 7 million and have 20 employees.

Total Voting Rights

2 March 2020 15:00 GMT     Transparency Directive Voting Rights and Capital   The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 29 February 2020 the issued share capital of AstraZeneca PLC with voting rights is 1,312,206,278 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,312,206,278.   The above figure for the total number of voting rights may be used by shareholders as the denominator for the

NRC Group ASA - Appointed to a contract in Sweden - SEK 75 million

Consto AB has appointed NRC Sverige AB, a company wholly owned by NRC Group ASA, to a contract for ground, foundation and construction work at Almnäs in Sweden. The contract is valued at approximately SEK 75 million, and the work will commence in March 2020, and the project is scheduled for completion in December 2021.  For further information, please contact: Henning Olsen, CEO of NRC Group, + 47 91 74 15 92. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Systemair acquires distributor in Denmark

Pressrelease 2 March 2020 Systemair AB (NASDAQ OMX Stockholm: SYSR) has acquired 60 percent of the Danish sales company Tempus Heat A/S. The company is headquartered in Horsens, Denmark and is also established with a smaller sales office outside Copenhagen. Tempus has a turnover of approximately SEK 15 million. The company is a distributor of Frico's heating products and is also providing service of the products. The company employs 5 persons and the company will immediately be renamed Frico A/S. "We see good opportunities to increase our market shares for Frico in Denmark. Tempus

AAK acquires 75 percent of Russian long-term partner Margaron

AAK has acquired 75 percent of NPO Margaron LLC, a producer of margarines, spreads, and bakery and confectionery fats, based in St. Petersburg, Russia. Margaron has been a trusted toll manufacturer to AAK for more than a decade and had last year revenues of approximately SEK 280 million. “Russia and the CIS countries have a population of more than 200 million people and is a highly attractive market for AAK”, said Johan Westman, President and CEO. “It is also one of the world’s largest chocolate and confectionery markets with strong potential for our Special Nutrition, Bakery, and Dairy

New trial with Diamyd[®] in autoimmune diabetes has started recruiting patients in Norway

GADinLADA is the first clinical phase II trial with the diabetes vaccine Diamyd[®] adminstered directly into the lymph node in patients with the form of autoimmune diabetes called LADA (Latent Autoimmune Diabetes in Adults).The investigator initiated clinical phase II trial, GADinLADA, is now open for recruitment at the Norwegian University of Science and Technology in Trondheim (NTNU), in cooperation with St. Olav’s University Hospital, Trondheim. The trial will also be conducted in Sweden at the Center for Diabetes, the Academic Specialist Center, an academic specialist unit that is run

The NDA Accelerator partners with BioStock to bring highly relevant communication services to biotech companies in the Nordics

The NDA Accelerator is launched by the NDA Group to support biotech companies to accelerate their drug development by offering access to affordable expert advice, regulatory support and training. Through a ground-breaking partnership with BioStock,the NDA Accelerator is now able to offer its members market leading services and capabilities to generate market awareness and investor interest.Small companies often lack the resources and capabilities of larger companies. With the explicit focus on small and very small biotech companies, the NDA Accelerator offers the promise of large company

New generation rocket engines to be tested at Esrange – SSC signs contract with Isar Aerospace

Swedish Space Corporation, SSC, and German space tech company Isar Aerospace have signed a long-term contract for testing of a new generation of European rocket engines for minilaunchers at Esrange Space Center in Sweden. The agreement includes a rocket stand for vertical tests and the agreement can be extended to include rocket stage tests with multiple rocket engines. SSC’s new engine and stage test capability plays a crucial part in supporting research and the development of rocket engines for minilaunchers in Europe. The first engine tests are planned for mid-2020 and the aim is to

Consent received from the bondholders in the written procedure

This press release may not be announced, published or distributed, in whole or in part, directly or indirectly, in the United States, Canada, Japan, Australia, Hong Kong, New Zealand, Singapore, South Africa or any other country where such publication or distribution would violate applicable laws or rules or would require additional documents to be prepared or registered or require any other actions to be taken, in addition to the requirements under Swedish law. This press release is not a prospectus or an offer to subscribe, acquire or transfer shares, bonds or other securities. For

Bactiguard completes acquisition of Vigilenz

Bactiguard Holding AB (publ) (“Bactiguard”) has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on 4 February 2020.All conditions precedent have been fulfilled and the first part of the total consideration, consisting of a cash payment of USD 4.5 million, has been paid. The remaining part of the consideration, 241 512 new class B-shares in Bactiguard, is subject to approval by the annual general meeting of shareholders in Bactiguard on 28 April 2020. The cash portion has been financed through bank facilities

SRV Group Plc’s Annual Report 2019 published

SRV GROUP PLC     ANNUAL FINANCIAL REPORT     2 MARCH 2019      15.30 EET SRV Group Plc’s Annual Report 2019 published SRV Group Plc’s Annual Report 2019 has been published today on 2 March 2020 on www.srv.fi/en/investors . Annual Report includes the Annual Review, the Financial Statements and the Report of the Board of Directors. The Annual Review includes the Corporate Governance Statement. The language versions are Finnish and English. Salary and remuneration report 2019 of SRV

There are no items matching the current filter
There are no more items matching the current filter
Back to top